ATE525366T1 - Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten - Google Patents
Benzoxazolderivate und pharmazeutische zubereitungen die diese enthaltenInfo
- Publication number
- ATE525366T1 ATE525366T1 AT03029917T AT03029917T ATE525366T1 AT E525366 T1 ATE525366 T1 AT E525366T1 AT 03029917 T AT03029917 T AT 03029917T AT 03029917 T AT03029917 T AT 03029917T AT E525366 T1 ATE525366 T1 AT E525366T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical preparations
- preparations containing
- containing same
- benzoxazole derivatives
- alkyl group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/329,547 US6653334B1 (en) | 2002-12-27 | 2002-12-27 | Benzoxazole compound and pharmaceutical composition containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE525366T1 true ATE525366T1 (de) | 2011-10-15 |
Family
ID=29584242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03029917T ATE525366T1 (de) | 2002-12-27 | 2003-12-29 | Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten |
Country Status (4)
Country | Link |
---|---|
US (1) | US6653334B1 (de) |
EP (1) | EP1433786B1 (de) |
JP (1) | JP4488732B2 (de) |
AT (1) | ATE525366T1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6653334B1 (en) * | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
JP4928261B2 (ja) * | 2003-06-18 | 2012-05-09 | トランザイム・ファーマ・インコーポレイテッド | モチリン受容体の大環状拮抗薬 |
US7452862B2 (en) * | 2003-07-31 | 2008-11-18 | Tranzyme Pharma, Inc. | Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists |
AU2004270538C1 (en) * | 2003-09-03 | 2010-01-14 | Kowa Co., Ltd | PPAR-activating compound and pharmaceutical composition containing same |
GB0401334D0 (en) * | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
JP2008520645A (ja) * | 2004-11-23 | 2008-06-19 | ファイザー・プロダクツ・インク | ジベンジルアミン化合物および誘導体 |
PL371841A1 (pl) * | 2004-12-20 | 2006-06-26 | ADAMED Sp.z o.o. | Nowe związki pochodne kwasu 3-fenylopropionowego |
US7301033B2 (en) * | 2005-01-27 | 2007-11-27 | Kowa Co., Ltd. | PPAR-activating compound |
WO2006082495A1 (en) * | 2005-02-02 | 2006-08-10 | Ranbaxy Laboratories Limited | Peroxisome proliferator activated receptor modulators |
PL1852426T3 (pl) * | 2005-02-23 | 2014-04-30 | Kowa Co | Sposób wytwarzania optycznie czynnego związku aktywującego PPAR oraz związku pośredniego |
EP1887005B1 (de) * | 2005-05-31 | 2010-04-21 | Kowa Co., Ltd. | Verfahren zur herstellung von optisch aktiven ppar-aktivierenden verbindungen und zwischenprodukte für die herstellung |
CN101277953A (zh) * | 2005-09-29 | 2008-10-01 | 塞诺菲-安万特股份有限公司 | 2-氨基噻唑类和2-氨基唑类衍生物、它们的制备方法及它们作为药物的用途 |
US7919506B2 (en) * | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
US8383660B2 (en) * | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
JP5243696B2 (ja) * | 2006-03-17 | 2013-07-24 | 田辺三菱製薬株式会社 | ベンゼン誘導体 |
US8088733B2 (en) * | 2006-07-06 | 2012-01-03 | Tranzyme Pharma Inc. | Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ253742A (en) | 1992-07-03 | 1997-06-24 | Smithkline Beecham Plc | Heterocyclylaminoalkoxy substituted phenyl derivatives and pharmaceutical compositions |
WO1996004261A1 (en) | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
AU1856997A (en) | 1996-02-02 | 1997-08-22 | Merck & Co., Inc. | Method for raising hdl cholesterol levels |
GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
JP2002543065A (ja) * | 1999-04-28 | 2002-12-17 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Ppap受容体リガンドとしてのトリアリール酸誘導体 |
HUP0201291A3 (en) * | 1999-04-28 | 2002-11-28 | Sanofi Aventis Deutschland | Di-aryl acid derivatives as ppar receptor ligands and pharmaceutical compositions containing them |
JPWO2002046176A1 (ja) * | 2000-12-05 | 2004-04-08 | 日本ケミファ株式会社 | ペルオキシソーム増殖剤応答性受容体の活性化剤 |
CZ20033328A3 (cs) * | 2001-06-07 | 2004-06-16 | Eli Lilly And Company | Modulátory receptorů aktivovaných proliferátory peroxisomů (PPAR) |
EP1480957A1 (de) * | 2002-03-01 | 2004-12-01 | Smithkline Beecham Corporation | Hppars-aktivatoren |
US6653334B1 (en) * | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
-
2002
- 2002-12-27 US US10/329,547 patent/US6653334B1/en not_active Expired - Lifetime
-
2003
- 2003-12-24 JP JP2003428197A patent/JP4488732B2/ja not_active Expired - Fee Related
- 2003-12-29 AT AT03029917T patent/ATE525366T1/de not_active IP Right Cessation
- 2003-12-29 EP EP03029917A patent/EP1433786B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6653334B1 (en) | 2003-11-25 |
JP2004210776A (ja) | 2004-07-29 |
EP1433786B1 (de) | 2011-09-21 |
JP4488732B2 (ja) | 2010-06-23 |
EP1433786A1 (de) | 2004-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE525366T1 (de) | Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten | |
AR044036A1 (es) | Compuestos de pirazolopirimidinas y pirazolopiridinas como ligandos de receptor cannabinoide, composiciones farmaceuticas y usos de los mismos | |
DE60026318D1 (de) | Isoxazolin derivate und herbizide, die diese als aktiven bestandteil enthalten | |
DE60315615D1 (de) | Tricyclische verbindungen auf thiophengrundlage und pharmazeutische zusammensetzungen, die diese enthalten | |
MEP61208A (en) | Novel compounds having inhibitory activity against sodium-dependant transporter | |
ATE226574T1 (de) | 4,6-diarylpyrimidin-derivate und deren salze | |
EA200401613A1 (ru) | Лекарственное средство для лечения рака | |
BRPI0213243B8 (pt) | composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
EA200500006A1 (ru) | Лекарственное средство для лечения нейродегенеративных заболеваний | |
ATE503746T1 (de) | Neue imidazolidinderivate | |
DE60329513D1 (de) | Antagonist des melanin-concentrating-hormone-rezeptors, enthaltend ein benzimidazolderivat als wirkstoff | |
SE0201937D0 (sv) | Therapeutic agents | |
HUP0300370A2 (hu) | Antimikrobiális hatású 2-hidroxi-mutilin-karbamát-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE259376T1 (de) | Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren | |
ATE268751T1 (de) | Biphenylamidin-derivate | |
NO20042010L (no) | 4-imidazolin-2-on forbindelser | |
DE60205338D1 (de) | Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten | |
ATE399755T1 (de) | Aminoalkoholderivate, pharmazeutische zusammensetzungen, die diese enthalten, und verwendung davon | |
DE69919575D1 (de) | Benzoxazolderivate und medikamente die diese als aktiven wirkstoff enthalten | |
MA27091A1 (fr) | Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
ATE275560T1 (de) | Bemzimidazolverbindungen und medikamente die diese enthalten | |
DE69828087D1 (de) | Aminderivate | |
ATE327238T1 (de) | Pkb-3564-substanz mit die gefässneubildung hemmender wirkung | |
ATE420855T1 (de) | 2-substituierte vitamin-d-derivate | |
TH63479A (th) | สารประกอบเฮเทอโรไซคลิกใหม่ และการใช้ทางเภสัชกรรมของสารประกอบ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |